What is the scientific consensus on adhd?
The scientific consensus on ADHD, particularly in adolescents and adults with comorbid substance use disorder (SUD), emphasizes the importance of routine screening, integrated treatment approaches, and the use of long-acting stimulants as first-line pharmacotherapy . Consensus statements highlight the need for early recognition of ADHD in individuals with SUD, prompt initiation of diagnostic procedures, and the preference for combined pharmacological and psychosocial treatments . Additionally, involving patients and families in the management program, addressing coexisting conditions alongside ADHD, and implementing behavioral, medication, and educational interventions are crucial aspects of managing ADHD effectively . The consensus underscores the significance of a multidisciplinary approach tailored to the specific needs of each patient to achieve optimal outcomes in ADHD management.
Answers from top 5 papers
Papers (5) | Insight |
---|---|
Open access•Journal Article 1 Citations | The scientific consensus recommends routine screening, prompt diagnosis, and integrated treatment with medication and psychotherapy, including higher-dose long-acting stimulants, for adults with substance use disorder and ADHD. |
7 Citations | The scientific consensus on ADHD management includes a multidisciplinary approach involving education, family involvement, target outcomes, and treatment modalities like behavioral interventions, medications, and educational interventions. |
Open access•Journal Article 4 Citations | A panel of ADHD experts reached a high level of consensus on key criteria and therapeutic guidelines, providing valuable insights for clinical practice in managing ADHD. |
The scientific consensus recommends routine screening for ADHD in adolescents with substance use disorder, long-acting stimulants as first-line treatment, and integrating pharmacotherapy with psychosocial interventions. | |
The scientific consensus recommends routine screening for ADHD in adolescents with substance use disorder, long-acting stimulants as first-line treatment, and integrating pharmacotherapy with psychosocial interventions. |